WETO vs IVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 21, 2026

WETO

32.1
AI Score
VS
IVF Wins

IVF

37.8
AI Score

Investment Advisor Scores

WETO

32score
Recommendation
EXTENDED

IVF

38score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric WETO IVF Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -45.0% 16.7% IVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 32.1/100 37.8/100 IVF
Profit Margin -75.9% -70.2% IVF
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED SELL WETO

Relative Price Performance (Last 90 Days)

WETO 1M: +22636.0% · 3M: +2696.8% IVF 1M: +3.9% · 3M: -32.9%

Current Technical Phase

WETO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (412.3% over 20 days), RSI 69

RSI (14): 68.8 · Price: $26.01

IVF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.8 · Price: $1.06

Fundamentals Snapshot

Metric WETO IVF
Market Cap
Forward P/E 0.0 -0.1
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth -0.5% 0.2%
Gross Margin 0.1% 0.4%
Operating Margin -1.2% -0.6%
EPS -19.77 353.17
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, IVF is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.